Uas Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-05-2024
- Paid Up Capital ₹ 0.50 M
as on 15-05-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -0.40%
(FY 2019)
- Profit -15.61%
(FY 2019)
- Ebitda -12.69%
(FY 2019)
- Net Worth -8.97%
(FY 2019)
- Total Assets 15.09%
(FY 2019)
About Uas Pharmaceuticals (India)
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashi Dayal, Anuj Seth, Urvashi Seth, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397DL2007PTC214233
- Company No.
214233
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2007
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Uas Pharmaceuticals (India)?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urvashi Seth  | Director | 20-Mar-2007 | Current |
Ashi Dayal  | Director | 31-Mar-2015 | Current |
| Anuj Seth | Director | 09-Jun-2009 | Current |
| Ajit Seth | Director | 20-Mar-2007 | Current |
Financial Performance of Uas Pharmaceuticals (India).
Uas Pharmaceuticals (India) Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 0.4% decrease. The company also saw a substantial fall in profitability, with a 15.61% decrease in profit. The company's net worth dipped by a decrease of 8.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uas Pharmaceuticals (India)?
In 2019, Uas Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uas Pharmaceuticals (India)?
Uas Pharmaceuticals (India) has a workforce of 15 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uas Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uas Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
